<> <http://www.w3.org/2000/01/rdf-schema#comment> "The repository administrator has not yet configured an RDF license."^^<http://www.w3.org/2001/XMLSchema#string> .
<> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/66018> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/AcademicArticle> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/dc/terms/title> "CLINICAL AND LABORATORY FEATURES IN PATIENTS RECOVERED FROM COVID-19 PNEUMONIA"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/ontology/bibo/abstract> "The post-acute sequelae of SARS-CoV-2 infection (Long COVID) represent a growing global health challenge. While acute phase laboratory changes are well-documented, the persistence of hematological and biochemical abnormalities months after recovery from COVID-19 pneumonia remains insufficiently characterized, particularly in the Central Asian population. A retrospective, cross-sectional cohort study was conducted involving 120 participants. The primary group consisted of 80 patients who had recovered from moderate to severe COVID-19 pneumonia 3 to 6 months prior to the study. The control group included 40 healthy individuals with no history of SARS-CoV-2 infection. Clinical data, complete blood counts, coagulation profiles, and systemic inflammatory markers were analyzed. Statistical evaluation was performed using the Student’s t-test and chi-square test. Patients in the post-COVID group demonstrated persistent laboratory alterations compared to the control group. Statistically significant elevations were observed in D-dimer (0.65 ± 0.08 mg/L vs. 0.22 ± 0.04 mg/L, p &lt; 0.001), C-reactive protein (8.4 ± 1.2 mg/L vs. 2.5 ± 0.5 mg/L, p &lt; 0.01), and ferritin (245 ± 25 mcg/L vs. 110 ± 15 mcg/L, p &lt; 0.01). Furthermore, relative lymphopenia (21.5 ± 1.8% vs. 32.4 ± 2.1%, p &lt; 0.05) remained prevalent in the recovered cohort. Recovery from the acute phase of COVID-19 pneumonia does not equate to complete physiological normalization. Persistent systemic inflammation and subclinical endotheliopathy can last for months, necessitating long-term clinical and laboratory monitoring to prevent delayed cardiovascular and pulmonary complications."^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/dc/terms/date> "2026-03-13" .
<https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
<https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c> <http://xmlns.com/foaf/0.1/name> "Center for Tech and Media Research"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/dc/terms/publisher> <https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c> .
<https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Collection> .
<https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36> <http://xmlns.com/foaf/0.1/name> "Multidisciplinary Journal of Science and Technology"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/ontology/bibo/status> <http://purl.org/ontology/bibo/status/published> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-21d1fedb221a0bf3c90f1ea72611d72c> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/66018#authors> .
<https://arxiv.universalpublishings.com/id/eprint/66018#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_1> <https://arxiv.universalpublishings.com/id/person/ext-21d1fedb221a0bf3c90f1ea72611d72c> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-1aa4744deb609b95a357fd888b0a8d55> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/66018#authors> .
<https://arxiv.universalpublishings.com/id/eprint/66018#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_2> <https://arxiv.universalpublishings.com/id/person/ext-1aa4744deb609b95a357fd888b0a8d55> .
<https://arxiv.universalpublishings.com/id/person/ext-1aa4744deb609b95a357fd888b0a8d55> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-1aa4744deb609b95a357fd888b0a8d55> <http://xmlns.com/foaf/0.1/givenName> "F.D."^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-1aa4744deb609b95a357fd888b0a8d55> <http://xmlns.com/foaf/0.1/familyName> "Axmatjonova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-1aa4744deb609b95a357fd888b0a8d55> <http://xmlns.com/foaf/0.1/name> "F.D. Axmatjonova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-21d1fedb221a0bf3c90f1ea72611d72c> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-21d1fedb221a0bf3c90f1ea72611d72c> <http://xmlns.com/foaf/0.1/givenName> "R.Z."^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-21d1fedb221a0bf3c90f1ea72611d72c> <http://xmlns.com/foaf/0.1/familyName> "Umurzaqova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-21d1fedb221a0bf3c90f1ea72611d72c> <http://xmlns.com/foaf/0.1/name> "R.Z. Umurzaqova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/EPrint> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/ArticleEPrint> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/repository> .
<https://arxiv.universalpublishings.com/id/eprint/66018> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <https://arxiv.universalpublishings.com/id/eprint/66018/> .
<https://arxiv.universalpublishings.com/id/eprint/66018/> <http://purl.org/dc/elements/1.1/title> "HTML Summary of #66018 \n\nCLINICAL AND LABORATORY FEATURES IN PATIENTS RECOVERED FROM COVID-19 PNEUMONIA\n\n" .
<https://arxiv.universalpublishings.com/id/eprint/66018/> <http://purl.org/dc/elements/1.1/format> "text/html" .
<https://arxiv.universalpublishings.com/id/eprint/66018/> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/66018> .